Barral-Netto M - Search Results

1

Cytotoxicity in patients with different clinical forms of Chagas' disease.

Brodskyn CI, Barral A, Bulhões MA, Souto T, Machado WC, Barral-Netto M. Brodskyn CI, et al. Clin Exp Immunol. 1996 Sep;105(3):450-5. doi: 10.1046/j.1365-2249.1996.d01-785.x. Clin Exp Immunol. 1996. PMID: 8809133 Free PMC article.

2

Cytotoxicity in human mucosal and cutaneous leishmaniasis.

Barral-Netto M, Barral A, Brodskyn C, Carvalho EM, Reed SG. Barral-Netto M, et al. Parasite Immunol. 1995 Jan;17(1):21-8. doi: 10.1111/j.1365-3024.1995.tb00962.x. Parasite Immunol. 1995. PMID: 7731732

3

Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis.

Brodskyn CI, Barral A, Boaventura V, Carvalho E, Barral-Netto M. Brodskyn CI, et al. J Immunol. 1997 Nov 1;159(9):4467-73. J Immunol. 1997. PMID: 9379046

4

Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi.

Carvalho EM, Barral A, Pedral-Sampaio D, Barral-Netto M, Badaró R, Rocha H, Johnson WD Jr. Carvalho EM, et al. J Infect Dis. 1992 Mar;165(3):535-40. doi: 10.1093/infdis/165.3.535. J Infect Dis. 1992. PMID: 1347057

5

Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis.

Barral-Netto M, Barral A, Santos SB, Carvalho EM, Badaro R, Rocha H, Reed SG, Johnson WD Jr. Barral-Netto M, et al. J Immunol. 1991 Jul 1;147(1):281-4. J Immunol. 1991. PMID: 1904902

6

Transforming growth factor-beta in tegumentary leishmaniasis.

Barral-Netto M, Barral A. Barral-Netto M, et al. Braz J Med Biol Res. 1994 Jan;27(1):1-9. Braz J Med Biol Res. 1994. PMID: 8173524 Review.

7

Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis.

Schriefer A, Barral A, Carvalho EM, Barral-Netto M. Schriefer A, et al. Clin Exp Immunol. 1995 Dec;102(3):535-40. doi: 10.1111/j.1365-2249.1995.tb03849.x. Clin Exp Immunol. 1995. PMID: 8536369 Free PMC article.

8

Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis.

Bacellar O, Brodskyn C, Guerreiro J, Barral-Netto M, Costa CH, Coffman RL, Johnson WD, Carvalho EM. Bacellar O, et al. J Infect Dis. 1996 Jun;173(6):1515-8. doi: 10.1093/infdis/173.6.1515. J Infect Dis. 1996. PMID: 8648233

9

Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis.

Bomfim G, Nascimento C, Costa J, Carvalho EM, Barral-Netto M, Barral A. Bomfim G, et al. Exp Parasitol. 1996 Nov;84(2):188-94. doi: 10.1006/expr.1996.0104. Exp Parasitol. 1996. PMID: 8932768

10

Production of host-protective (IFN-gamma), host-impairing (IL-10, IL-13) and inflammatory (TNF-alpha) cytokines by PBMC from leprosy patients stimulated with mycobacterial antigens.

Machado P, Abrams J, Santos S, Brennan P, Barral A, Barral-Netto M. Machado P, et al. Eur J Dermatol. 1998 Mar;8(2):98-103. Eur J Dermatol. 1998. PMID: 9649657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters